Skip to main content

Table 3 Comparison of outcomes between the two groups in the matched cohort

From: Effect of tranexamic acid on mortality in patients with haemoptysis: a nationwide study

 

Matched

Control (n = 9933)

Tranexamic acid (n = 9933)

Risk difference (95% CI)

p value

Primary outcome

 In-hospital mortality

1141 (11.5%)

890 (9.0%)

− 2.5 (− 3.5 to − 1.6) %

< 0.001

Secondary outcomes

 Length of hospital stay, days

18 ± 24

16 ± 18

− 2.4 (− 3.1 to − 1.8)

< 0.001

 Discharged to home

8124 (81.8%)

8410 (84.7%)

2.9 (1.7 to 4.1%)

< 0.001

 Total health care cost for the admission, USD

7573 ± 10,085

6757 ± 9127

− 816 (− 1109 to − 523)

< 0.001

 Thromboembolism

212 (2.1%)

232 (2.3%)

0.2 (− 0.2 to 0.6%)

0.34

 Seizure

9 (0.0%)

5 (0.0%)

  
  1. Categorical variables are expressed as the number (%), and continuous variables are presented as the mean ± standard deviation. Risk difference and 95% confidence interval were obtained by generalised estimating equation models with identity link functions
  2. USD United States dollars